ID   DCLK2_RAT               Reviewed;         767 AA.
AC   Q5MPA9; Q5MPA7; Q5MPA8; Q5MPB0;
DT   23-MAR-2010, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   02-OCT-2024, entry version 150.
DE   RecName: Full=Serine/threonine-protein kinase DCLK2;
DE            EC=2.7.11.1;
DE   AltName: Full=CaMK-like CREB regulatory kinase 2;
DE            Short=CL2;
DE            Short=CLICK-II;
DE            Short=CLICK2;
DE   AltName: Full=Doublecortin-like and CAM kinase-like 2;
DE   AltName: Full=Doublecortin-like kinase 2;
GN   Name=Dclk2; Synonyms=Dcamkl2, Dck2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), NUCLEOTIDE SEQUENCE [MRNA]
RP   OF 269-386 (ISOFORM 3), INTERACTION WITH MICROTUBULES, SUBCELLULAR
RP   LOCATION, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-438.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=15611072; DOI=10.1074/jbc.m411027200;
RA   Edelman A.M., Kim W.Y., Higgins D., Goldstein E.G., Oberdoerster M.,
RA   Sigurdson W.;
RT   "Doublecortin kinase-2, a novel doublecortin-related protein kinase
RT   associated with terminal segments of axons and dendrites.";
RL   J. Biol. Chem. 280:8531-8543(2005).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-662 AND THR-681, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
CC   -!- FUNCTION: Protein kinase with a significantly reduced Ca(2+)+/CAM
CC       affinity and dependence compared to other members of the CaMK family.
CC       May play a role in the down-regulation of CRE-dependent gene activation
CC       probably by phosphorylation of the CREB coactivator CRTC2/TORC2 and the
CC       resulting retention of TORC2 in the cytoplasm (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts with MAPK8IP1/JIP-1, MAPK8IP2/JIP-2, MAPK9/JNK2,
CC       PPP1R9B/NEURABIN-2 and actin (By similarity). Binds to and stabilizes
CC       microtubules; binding affinity is strongly reduced by
CC       autophosphorylation. {ECO:0000250, ECO:0000269|PubMed:15611072}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:15611072}. Note=Colocalizes with microtubules. When
CC       overexpressed in sympathetic neurons, localizes to cell body and to the
CC       terminal segments of axons and dendrites.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5MPA9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5MPA9-2; Sequence=VSP_038898, VSP_038899;
CC       Name=3;
CC         IsoId=Q5MPA9-3; Sequence=VSP_038897;
CC   -!- DOMAIN: The doublecortin domains are involved in the binding to
CC       microtubules.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY673997; AAV85461.1; -; mRNA.
DR   EMBL; AY673998; AAV85462.1; -; mRNA.
DR   EMBL; AY673999; AAV85463.1; -; mRNA.
DR   EMBL; AY674000; AAV85464.1; -; mRNA.
DR   RefSeq; NP_001009691.3; NM_001009691.3. [Q5MPA9-1]
DR   RefSeq; NP_001182761.1; NM_001195832.1. [Q5MPA9-2]
DR   RefSeq; XP_006232741.1; XM_006232679.3.
DR   RefSeq; XP_006232743.1; XM_006232681.3. [Q5MPA9-3]
DR   RefSeq; XP_017446402.1; XM_017590913.1.
DR   AlphaFoldDB; Q5MPA9; -.
DR   SMR; Q5MPA9; -.
DR   BioGRID; 259725; 2.
DR   IntAct; Q5MPA9; 1.
DR   MINT; Q5MPA9; -.
DR   STRING; 10116.ENSRNOP00000062805; -.
DR   iPTMnet; Q5MPA9; -.
DR   PhosphoSitePlus; Q5MPA9; -.
DR   PaxDb; 10116-ENSRNOP00000053894; -.
DR   Ensembl; ENSRNOT00055043536; ENSRNOP00055035529; ENSRNOG00055025208. [Q5MPA9-1]
DR   Ensembl; ENSRNOT00060054927; ENSRNOP00060045420; ENSRNOG00060031672. [Q5MPA9-1]
DR   GeneID; 310698; -.
DR   KEGG; rno:310698; -.
DR   UCSC; RGD:1308384; rat. [Q5MPA9-1]
DR   AGR; RGD:1308384; -.
DR   CTD; 166614; -.
DR   RGD; 1308384; Dclk2.
DR   VEuPathDB; HostDB:ENSRNOG00000016550; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   InParanoid; Q5MPA9; -.
DR   OrthoDB; 2956627at2759; -.
DR   PhylomeDB; Q5MPA9; -.
DR   TreeFam; TF318770; -.
DR   PRO; PR:Q5MPA9; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000016550; Expressed in cerebellum and 19 other cell types or tissues.
DR   ExpressionAtlas; Q5MPA9; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0021766; P:hippocampus development; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISO:RGD.
DR   GO; GO:1900181; P:negative regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0034504; P:protein localization to nucleus; ISO:RGD.
DR   GO; GO:0021860; P:pyramidal neuron development; ISO:RGD.
DR   CDD; cd17141; DCX1_DCLK2; 1.
DR   CDD; cd17069; DCX2; 1.
DR   CDD; cd14184; STKc_DCKL2; 1.
DR   Gene3D; 3.10.20.230; Doublecortin domain; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR003533; Doublecortin_dom.
DR   InterPro; IPR036572; Doublecortin_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; SERINE/THREONINE-PROTEIN KINASE; 1.
DR   PANTHER; PTHR24347:SF376; SERINE_THREONINE-PROTEIN KINASE DCLK2; 1.
DR   Pfam; PF03607; DCX; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00537; DCX; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF89837; Doublecortin (DC); 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50309; DC; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Cytoskeleton; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..767
FT                   /note="Serine/threonine-protein kinase DCLK2"
FT                   /id="PRO_0000393224"
FT   DOMAIN          72..158
FT                   /note="Doublecortin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00072"
FT   DOMAIN          196..279
FT                   /note="Doublecortin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00072"
FT   DOMAIN          409..666
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..44
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          301..391
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          721..767
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        7..23
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        27..41
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        301..383
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        738..754
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        530
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         415..423
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         438
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         61
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N568"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N568"
FT   MOD_RES         662
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         681
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   VAR_SEQ         320..335
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15611072"
FT                   /id="VSP_038897"
FT   VAR_SEQ         707..715
FT                   /note="NTALDKEGQ -> VQGHEHGSR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15611072"
FT                   /id="VSP_038898"
FT   VAR_SEQ         716..767
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15611072"
FT                   /id="VSP_038899"
FT   MUTAGEN         438
FT                   /note="K->A: Loss of autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15611072"
FT   CONFLICT        126
FT                   /note="V -> I (in Ref. 1; AAV85464)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        308
FT                   /note="P -> L (in Ref. 1; AAV85464)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        387
FT                   /note="R -> C (in Ref. 1; AAV85461/AAV85462)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   767 AA;  84016 MW;  2348331B01FF5B79 CRC64;
     MASTRSIELE HFEERDKRPR PGSRRGAPSS SGGSSISGPK GNGLIPSPAH SAHCSFYRTR
     TLQALSSEKK AKKARFYRNG DRYFKGLVFA ISSDRFRSFD ALLIELTRSL SDNVNLPQGV
     RTIYTVDGSR KVTSLDELLE GESYVCASNE PFRKVDYTKN VNPNWSVNIK GGTTRTLAVA
     SAKSEVKESK DFIKPKLVTV IRSGVKPRKA VRILLNKKTA HSFEQVLTDI TEAIKLDSGV
     VKRLCTLDGK QVTCLQDFFG DDDVFIACGP EKYRYAQDDF VLDHSECRVL KSSYSRASAA
     KYSGSRSPGL SRRSKSPASV KRAGHSSAYS TAKSPVNGTP SSQLSTPKST KSSSSSPTSP
     GSFRGLKQIS AQGRSSSNVN GGPELDRCMS PEGVNGNRCS ESFTLLEKYR IGKVIGDGNF
     AVVKECMDRS TGKEFALKII DKAKCCGKEH LIENEVSILR RVKHPNIIML VEEMETTTEL
     FLVMELVKGG DLFDAITSST KYTERDGSAM VYNLASALRY LHGLSIVHRD IKPENLLVCE
     YPDGTKSLKL GDFGLATVVE GPLYTVCGTP TYVAPEIIAE TGYGLKVDVW AAGVITYILL
     CGFPPFRSEN NLQEDLFDQI LAGKLEFPAP YWDNITDSAK ELISQMLQVN VEARCTAGEI
     LSHPWVSDDA SQENNMQAEV TGKLKQHFNN ALPKQNSTTT GVSVIMNTAL DKEGQVFCSK
     HCRDSSKSSR EQTSAREAPP PPESPRPPGP PATSGCDPAG TWRRHRD
//
